Aimee Blake

431 total citations
23 papers, 286 citations indexed

About

Aimee Blake is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Aimee Blake has authored 23 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Genetics and 10 papers in Immunology. Recurrent topics in Aimee Blake's work include Inflammatory Bowel Disease (12 papers), Eosinophilic Esophagitis (9 papers) and Microscopic Colitis (7 papers). Aimee Blake is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Eosinophilic Esophagitis (9 papers) and Microscopic Colitis (7 papers). Aimee Blake collaborates with scholars based in United Kingdom, United States and Canada. Aimee Blake's co-authors include Fatima Bhayat, Simon Travis, Karen Lasch, Russell D. Cohen, Séverine Vermeire, Uma Mahadevan, Marla C. Dubinsky, Qasim Khan, Shashi Adsul and Siew C. Ng and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Aimee Blake

22 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aimee Blake United Kingdom	8	195	152	109	100	81	23	286
Ilia Tikhonov United States	8	172 0.9×	136 0.9×	91 0.8×	90 0.9×	47 0.6×	14	282
Evelien Humblet Belgium	5	185 0.9×	143 0.9×	68 0.6×	88 0.9×	44 0.5×	10	248
Yoon‐Kyo An Australia	9	224 1.1×	179 1.2×	140 1.3×	53 0.5×	53 0.7×	24	329
Annick Moens Belgium	8	132 0.7×	115 0.8×	86 0.8×	67 0.7×	55 0.7×	17	207
Kimberly N. Weaver United States	8	189 1.0×	157 1.0×	84 0.8×	49 0.5×	37 0.5×	22	316
Martin Lukáš Czechia	9	150 0.8×	108 0.7×	103 0.9×	195 1.9×	120 1.5×	30	304
José Lázaro Pérez‐Calle Spain	6	161 0.8×	116 0.8×	67 0.6×	126 1.3×	67 0.8×	9	274
Lior Yahav Israel	8	290 1.5×	227 1.5×	124 1.1×	100 1.0×	26 0.3×	20	417
Eric J. Mao United States	6	203 1.0×	169 1.1×	90 0.8×	50 0.5×	30 0.4×	16	284
Klaus Theede Denmark	11	363 1.9×	320 2.1×	182 1.7×	61 0.6×	56 0.7×	27	498

Countries citing papers authored by Aimee Blake

Since Specialization

Citations

This map shows the geographic impact of Aimee Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee Blake more than expected).

Fields of papers citing papers by Aimee Blake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee Blake. The network helps show where Aimee Blake may publish in the future.

Co-authorship network of co-authors of Aimee Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee Blake. A scholar is included among the top collaborators of Aimee Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee Blake. Aimee Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blake, Aimee, et al.. (2024). Shear stress-induced restoration of pulmonary microvascular endothelial barrier function following ischemia reperfusion injury requires VEGFR2 signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(3). L389–L404.

Jairath, Vipul, et al.. (2021). Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis. Expert Review of Gastroenterology & Hepatology. 15(6). 711–722. 12 indexed citations

Card, Tim, Ryan C. Ungaro, Fatima Bhayat, et al.. (2019). Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post‐marketing data. Alimentary Pharmacology & Therapeutics. 51(1). 149–157. 28 indexed citations

Cohen, Russell D., Fatima Bhayat, Aimee Blake, & Simon Travis. (2019). The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn’s Disease: 4 Years of Global Post-marketing Data. Journal of Crohn s and Colitis. 14(2). 192–204. 49 indexed citations

Card, Tim, Ryan C. Ungaro, Fatima Bhayat, et al.. (2019). Su1835 – Vedolizumab Use is Not Associated with Increased Malignancy Incidence: Gemini Long-Term Safety Study Results and Post-Marketing Data. Gastroenterology. 156(6). S–628. 1 indexed citations

Shen, Bo, Aimee Blake, Karen Lasch, Michael Smyth, & Fatima Bhayat. (2019). Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experience. Gastroenterology report. 7(5). 322–330. 8 indexed citations

Cohen, R D, Fatima Bhayat, Aimee Blake, & Simon Travis. (2019). P500 Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics. Journal of Crohn s and Colitis. 13(Supplement_1). S362–S362. 1 indexed citations

Cohen, Russell D., Fatima Bhayat, Gary Hantsbarger, Aimee Blake, & Séverine Vermeire. (2018). DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists. Journal of Crohn s and Colitis. 12(supplement_1). S032–S034. 2 indexed citations

Ng, Siew C., Ida Hilmi, Aimee Blake, et al.. (2018). Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting. Inflammatory Bowel Diseases. 24(11). 2431–2441. 63 indexed citations

10.

Mahadevan, Uma, Séverine Vermeire, Karen Lasch, et al.. (2017). Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 45(7). 941–950. 78 indexed citations

11.

Palo, William, et al.. (2017). AODTH-003 Vedolizumab clinical and post-marketing safety experience of opportunistic infections. HighWire Press Open Archive. A200.1–A200. 1 indexed citations

12.

Feagan, Brian G., Fatima Bhayat, Javaria Mona Khalid, et al.. (2017). Incidence of Pneumonia and Other Respiratory Tract Infections with Vedolizumab Treatment for Inflammatory Bowel Disease: Clinical Trial Experience. Gastroenterology. 152(5). S580–S581. 1 indexed citations

13.

Bhayat, Fatima, Aimee Blake, & Simon Travis. (2017). P668 Post-marketing experience of vedolizumab in inflammatory bowel disease: analysis of pneumonia and other respiratory tract infections. Journal of Crohn s and Colitis. 11(suppl_1). S421–S422. 2 indexed citations

14.

Ng, S.C., et al.. (2017). DOP024 Vedolizumab clinical and post-marketing safety experience of opportunistic infections. Journal of Crohn s and Colitis. 11(suppl_1). S41–S41. 1 indexed citations

15.

Bhayat, Fatima, Aimee Blake, & Simon Travis. (2017). Post-Marketing Experience of Vedolizumab in Inflammatory Bowel Disease: Analysis of Pneumonia and Other Respiratory Tract Infections. Gastroenterology. 152(5). S580–S580. 2 indexed citations

16.

Ng, Siew C., et al.. (2017). Vedolizumab Clinical and Post-Marketing Safety Experience of Opportunistic Infections. Gastroenterology. 152(5). S575–S576. 2 indexed citations

17.

Blake, Aimee, et al.. (2017). P647 Tuberculosis in patients treated with vedolizumab: clinical trial and post-marketing case series. Journal of Crohn s and Colitis. 11(suppl_1). S410–S411. 2 indexed citations

18.

Bhayat, Fatima, et al.. (2016). Post-marketing Safety Experience with Vedolizumab: Skin Reactions (Psoriasiform and Eczematous). The American Journal of Gastroenterology. 111. S313–S313. 1 indexed citations

19.

Levy, Bruce, JW Rosson, & Aimee Blake. (2004). MRSA in patients presenting with femoral fractures. The Surgeon. 2(3). 171–172. 4 indexed citations

20.

Blake, Aimee, et al.. (1971). Coronary Artery-Right Atrial Fistula Secondary to Bullet Wound of the Heart: Report of a Case with Successful Surgical Repair. Military Medicine. 136(3). 267–270. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact